9 November 2017
A new study published in the New England Journal of Medicine has found that the risk of breast cancer recurring persists undiminished for at least 20 years after diagnosis, suggesting that hormonal treatments should continue for even longer to reduce the risk of late recurrence.
26 September 2017
The SO2S study, one of the largest ever studies of the treatment of stroke, has found no worthwhile benefit from giving patients oxygen during the first few days following stroke (JAMA, 26 September 2017).
29 August 2017
Anacetrapib reduces the risk of serious cardiovascular events among high-risk patients on intensive statin treatment.